The investigation of the plasma monocyte chemoattractant protein-1 and interleukin-1 $alpha$ levels and the relationship between these levels and number of blood lymphocytes and monocytes in calves with foot and mouth disease
Şap hastalıklı danalarda plazma monosit kemoatraktan protein-1 ve interlökin-1 $alpha$ düzeylerinin ve bu düzeylerle kan lenfosit ve monosit sayıları arasındaki ilişkilerin incelenmesi
The levels of MCP-1 and IL-la in plasma were found to be significantly increased in calves with foot and mouth disease compared to healthy group (p
📌 3 Key Takeaways
🎯
Objective & Hypothesis:In this study, detection of plasma monocyte chemoattractant protein-1 (MCP-1) and interleukin-1 (IL-la) levels and correlations between these levels and blood lymphocyte and monocyte numbers was aimed. 1-1.5 years old 16 calves with foot and mouth disease and 11 calves with healthy were used in study.
📊
Key Findings & Data:In this study, detection of plasma monocyte chemoattractant protein-1 (MCP-1) and interleukin-1 (IL-la) levels and correlations between these levels and blood lymphocyte and monocyte numbers was aimed. 1-1.5 years old 16 calves with foot and mouth disease and 11 calves with healthy were used in study.
💡
Conclusion & Impact:The levels of MCP-1 and IL-la in plasma were found to be significantly increased in calves with foot and mouth disease compared to healthy group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
In this study, detection of plasma monocyte chemoattractant protein-1 (MCP-1) and interleukin-1 (IL-la) levels and correlations between these levels and blood lymphocyte and monocyte numbers was aimed. 1-1.5 years old 16 calves with foot and mouth disease and 11 calves with healthy were used in study. The levels of MCP-1 and IL-la in plasma were found to be significantly increased in calves with foot and mouth disease compared to healthy group (p
Özet
Bu çalışmada, şap hastalıklı danalarda plazma monosit kemoatraktan protein-1 (MCP-1) ve interlökin 1-a (İL-la) düzeylerinin ve bu düzeyler ile kandaki lenfosit ve monosit sayıları arasındaki ilişkilerin incelenmesi amaçlandı. Bu amaçla, 1-1.5 yaşlarında 16 adet şap hastalıklı ve 11 adet sağlıklı dana kullanıldı. Şap hastalıklı danalarda plazma MCP-1 ve İL-la düzeyleri sağlıklı gruba göre önemli derecede yükselmiş bulundu (p
🔖
Cite This Article
ÇİFTÇİ, G., COŞKUNER, A., YARIM, G. F., NİSBET, C., ÖCAL, N. (2022). The investigation of the plasma monocyte chemoattractant protein-1 and interleukin-1 $alpha$ levels and the relationship between these levels and number of blood lymphocytes and monocytes in calves with foot and mouth disease. Ankara Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 53 - Sayı: 2, 91–95. https://ajindex.com/articles/445163
Aderka D, Holtmann H, Toker L, Hahn T, Wallach D (1986): Tumor necrosis factor induction by Sendai virus. J Immunol, 136, 2938-2342. 2.Apte RN, Voronov E (2002): Interleukin-I-a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol, 12,277-290. 3.Baggiolinl M, Dewald B, Moser B (1997): Human chemokines: an update. Annu Rev Immunol, 15, 675-705. 4.Boring L, Gosling J, Cleary M, Charo IF (1998): Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature, 394, 894- 897. 5.Breen EC, Rezai K, Nakajima K, Beall GN, Mitsuyasu RT, Hirano T, Kishimoto T, Martinez-Maza O (1990): Infection with HIV is associated with elevated IL-6 levels and production. J Immunol, 144,480-484. 6.Bubfeld D, Kaufmann A, Meyer RG, Gemsa D, Sprenger H (1998): Differential mononuclear leukocyte attracting chemokine production after stimulation with active and inactivated influenza A virus. Cell Immun, 186, 1-7. 7.Cushing SD, Berliner JA, Valente AJ, Territo MC, Navab M, Parhami F, Gerrity R, Schwartz CJ, Fogelman AM (1990): Minimally modified low density lipoprotein induces monocyte chemotaclic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci USA, 87, 5134-5138. 8.Davies C (1994): Principles. In The Immunoassay Handbook. D. Wild, ed. Stockton Press, New York, p. 3-47. 9.Dinarello CA (1996): Biologic basis for interleukin-1 in disease. Blood, 87, 2095-2147. 10.Dinter Z, Morein B (1990):
Virus Infections of Ruminants, Elsevier Science Publishers B.V. p. 506-508. 11.Dunphy J, Horvath A, Barcham G, Balic A, Bischof R, Meeusen E (2001): Isolation, characterisation and expression of mRNAs encoding the ovine CC chemokines, monocyte chemoattractant protein (MCP)-Jalpha and -2. Vet Immunol Immunopathol, 82, 153-164. 12.Eckersall PD (2000): Recent advances and future prospects for the use of acute phase proteins as markers of disease in animals. Revue Med Vet, 151, 577-584. 13.England JM, Rowan RM, van Assendelft OW, Coulter WH, Groner W, Jones AR, Koepke JA, Lewis SM, Shinton NK, Thorn R (1984): Protocol for evaluation of automated blood cell counters. International Committee for Standardization in Haematology (ICSH). Clin Lab Haematol, 6, 269-84. 14.Gangur V, Birmingham NP, Thanesvorakul S (2002): Chemokines in health and disease. Vet Immunol Immunopathol, 86, 127-136. 15.Gu L, Tseng S, Rollins BJ (1999): Monocyte chemoattractant protein-1. Chem Immunol, 72, 7- 29. 16.Horadagoda NU, Kno